Results 231 to 240 of about 17,468,048 (391)

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study. [PDF]

J Intensive Care, 2021
Dahlberg S, Schött U, Kander T.
europepmc   +1 more source

Liver Transplantation for Primary Biliary Cirrhosis [PDF]

, 1989
Carcassonne, Christian, Makowka, Leonard, Starzl, Thomas, Todo, Satoru, Tzakis, Andreas   +4 more
core   +1 more source

Study on Risk Factors for Excessive Prolongation of International Normalized Ratio of Prothrombin Time in Patients Receiving Warfarin

, 2005
Makoto Hayashi, Morihiro Okada, Akira Takahashi, Ken Iritani, Tatuo Suzuki, Toshio Fukuoka   +5 more
openalex   +2 more sources

Monitoring Oral Anticoagulant Therapy by the Prothrombin Time: Reporting the Coagulation Activity or the International Normalized Ratio? [PDF]

, 1994
A.M.H.P. van den Besselaar
openalex   +1 more source

Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis

Hepatology Research, EarlyView.
ABSTRACT Background Hepatocellular carcinoma (HCC) with Vp4 portal vein tumor thrombosis (PVTT) has an extremely poor prognosis, and evidence for effective systemic therapy is limited. Preclinical studies suggest that hypofractionated radiation therapy (HFRT) may enhance immune checkpoint inhibitor (ICI) efficacy through immunogenic cell death and ...
Masahiko Tameda, Hideaki Tanaka, Yutaka Toyomasu, Mizuki Kawachi, Hirono Owa, Mone Tsukimoto, Yasuyuki Tamai, Naoto Fujiwara, Ryuta Shigefuku, Suguru Ogura, Yoshihito Nomoto, Hayato Nakagawa   +11 more
wiley   +1 more source

The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Getu F, Alemayehu E, Tesfaye A, Genanew B, Walle M.   +4 more
europepmc   +1 more source

The relationship of age, sex and prothrombin time related to the severity of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis. [PDF]

F1000Res, 2022
Mirza AF, Halim C, Sari MI.
europepmc   +1 more source

Clinical Outcomes of Reduced‐Dose Cabozantinib as Third‐ or Later‐Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real‐World Study

Hepatology Research, EarlyView.
In this real‐world post‐ICI setting, cabozantinib demonstrated meaningful clinical activity even at reduced doses, with disease control achieved in nearly half of patients. Importantly, preserved liver function (Child–Pugh class A) was the only determinant of both disease control and overall survival.
Teiji Kuzuya, Hisanori Muto, Yoshihiko Tachi, Mizuki Ariga, Sayaka Morisaki, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, Mitsuo Nagasaka, Ryoji Miyahara, Yoshiki Hirooka   +13 more
wiley   +1 more source

Platelet Count to Prothrombin Time: A Noninvasive Predictor of Esophageal Varices in Patients With Chronic Liver Disease. [PDF]

Cureus
Rizvi SRA, Wallam MDA, Siddiqui AR, Haqqi SAUH, Farrukh ZUI, Niaz SK, Farooq MU, Kakar F, Hashmi AA.   +8 more
europepmc   +1 more source

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models. [PDF]

Front Vet Sci, 2022
De Pablo-Moreno JA, Liras A, Revuelta L.
europepmc   +1 more source